SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer. Dr. Fero brings more than 30 years of experience leading startups, developing commercial software, researching biology and physics and working […]
Upgraded MassFluidix HC system launched in response to customer feedback, optimizing efficiency and quality of mass photometry experiments Refeyn’s new MassFluidix 2nd generation microfluidic chip enables rapid sample dilution and mass photometry measurement in each of its five channels. Oxford, UK – Refeyn, the company behind pioneering mass photometry technologies, has taken another step to assure […]
Munich, Germany — Last week, NanoTemper Technologies introduced Dianthus uHTS, greatly increasing the throughput capabilities of their breakthrough Spectral Shift technology. Spectral Shift is valued by scientists for easy setup of immobilization-free binding affinity measurements and minimal sample requirements, and Dianthus uHTS brings this technology into an automated 1536-well plate-based format. “With Dianthus uHTS we […]
Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the signing of a new Research Collaboration Agreement (RCA) with the National Cancer Centre of Singapore (NCCS). This collaboration aims to accelerate […]
Amsterdam-based LUMICKS signs €20 million venture debt with EIB to accelerate the development and launch of its new product, designed to advance immunotherapy development for cancer research. LUMICKS’ next generation high-throughput cell avidity platform aims to transform the drug discovery process by replacing traditional screening methods, expediting development for life-saving treatments, and improving reliability in […]
The San Francisco-based company with an R&D facility in Bilbao has also unveiled its Platforma.bio Software Development Kit, transforming how biologists analyze genomic data to drive drug discovery and advance adjacent fields in medicine. This latest financing bolsters the company’s efforts to transform computational biology on a global scale and empower researchers with innovative tools […]
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer Rockville, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024. In […]
Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA sequence coveragei for more confident characterization, while new LC-MS-grade reagents increase sensitivity and improve detection accuracy of RNA components.ii New waters_connect™ MAP Sequence […]
CALIBRE SCIENTIFIC ACQUIRES MRC, A US-BASED MANUFACTURER OF REAGENTS FOR THE ISOLATION AND ANALYSIS OF RNA AND DNA Calibre Scientific has acquired Molecular Research Center, Inc., Founded in 1989 and based in Ohio, USA, MRC is recognized for its expertise in RNA isolation technologies. MRC develops and manufactures reagents and kits used in molecular biology, biotechnology, […]
CALIBRE SCIENTIFIC ACQUIRES INVITECH, A UK-BASED SUPPLIER OF IN-VITRO DIAGNOSTICS AND RESEARCH KITS Calibre Scientific has acquired Invitech Ltd., a UK-based supplier of in-vitro diagnostics and research kits to clinical laboratories, CRO’s, public institutions and universities in the British Isles. Their products include HIV/HCV test kits (including PoC tests), pregnancy tests, ELISA kits, Lyme Disease test […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
